You are here:

Gilead Sciences Ltd

Name SMC ID No Status Sub. Type
 
Adefovir dipivoxil (Hepsera®) 54/03 Restricted Resubmission
Adefovir dipivoxil (Hepsera®) 54/03 Not Recommended Full submission
aztreonam (Cayston) 753/12 Not Recommended Full submission
aztreonam lysine (Cayston) 753/12 Restricted Resubmission
cobicistat (Tybost) 933/13 Not Recommended Non submission
elvitegravir 150mg, cobicistat 150mg, emtricitabine 200mg, tenofovir disoproxil (as fumarate) 245mg film coated tablet (Stribild®) 887/13 Accepted Full submission
elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide fumarate (Genvoya) 1142/16 Accepted Full submission
elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil (as fumarate) (Stribild) 1310/18 Not Recommended Non submission
emtricitabine / tenofovir / rilpivirine (Eviplera) 759/12 Accepted Abbreviated Submission
Emtricitabine 200 mg hard capsules (Emtriva®) 105/04 Accepted Resubmission
Emtricitabine 200mg hard capsules (Emtriva®) 105/04 Not Recommended Full submission
emtricitabine/tenofovir alafenamide (Descovy) 1169/16 Accepted Abbreviated Submission
emtricitabine/tenofovir disoproxil (Truvada) 1225/17 Accepted Full submission
Emtricitabine/tenofovir disoproxil 200 mg / 245 mg tablet (Truvada®) 237/06 Accepted Abbreviated Submission
emtricitabine/tenofovir disoproxil 200mg/245mg film-coated tablets (Truvada) 1263/17 Not Recommended Non submission
idelalisib (Zydelig) 1212/16 Not Recommended Non submission
idelalisib (Zydelig) 1026/15 Restricted Full submission
idelalisib (Zydelig) 1039/15 Accepted Full submission
ledipasvir-sofosbuvir (Harvoni) 1030/15 Restricted Full submission
ledipasvir/sofosbuvir (Harvoni) 1084/15 Restricted Full submission
rilpivirine 25mg, emtricitabine 200mg, tenofovir disoproxil (as fumarate) 245mg tablet (Eviplera®) 951/14 Accepted Full submission
rilpivirine/emtricitabine/tenofovir alafenamide (Odefsey) 1189/16 Accepted Abbreviated Submission
sofosbuvir 400mg tablet (Sovaldi®) 964/14 Accepted Full submission
sofosbuvir/velpatasvir (Epclusa) 1195/16 Restricted Full submission
sofosbuvir/velpatasvir (Epclusa) 1271/17 Restricted Full submission
tenofovir (Viread) 479/08 Accepted Full submission
tenofovir alafenamide (Vemlidy) 1238/17 Not Recommended Non submission
tenofovir disoproxil (Viread) 720/11 Accepted Full submission
tenofovir disoproxil (Viread) 900/13 Restricted Abbreviated Submission
tenofovir disoproxil (Viread) 904/13 Restricted Abbreviated Submission
tenofovir disoproxil (Viread) 905/13 Restricted Abbreviated Submission
Tenofovir disoproxil fumarate (Viread®) 03/02 Restricted Full submission

Back